Chemed (NYSE: CHE) CEO trims stake with 1,500-share open-market sale

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Chemed Corporation president and CEO Kevin J. McNamara completed an open-market sale of company Capital Stock. On March 27, 2026, he sold 1,500 shares at a weighted average price of $369.37 per share in multiple trades.

The shares were sold at prices ranging from $365.76 to $373.24. Following this transaction, McNamara directly holds 92,219 shares of Chemed stock.

Insider Trade Summary

Net Seller: 1,500 shares ($554,055)

Net Sell 1 txn

Insider MCNAMARA KEVIN J

Role president and CEO

Sold 1,500 shs ($554K)

Type	Security	Shares	Price	Value
Sale	Capital Stock	1,500	$369.37	$554K

Holdings After Transaction: Capital Stock — 92,219 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Shares sold: 1,500 shares Weighted average sale price: $369.37/share Post-transaction holdings: 92,219 shares +1 more

4 metrics

Shares sold 1,500 shares Capital Stock sold on March 27, 2026

Weighted average sale price $369.37/share Open-market sale on March 27, 2026

Post-transaction holdings 92,219 shares Shares directly owned after the sale

Sale price range $365.76–$373.24/share Range of prices for multiple sale executions

Key Terms

open-market sale, weighted average price, Capital Stock, Form 4

4 terms

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Capital Stock financial

"security_title: "Capital Stock""

Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.

Form 4 regulatory

"within the ranges set forth in footnote (1) of this Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

03/30/2026 - 12:42 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCNAMARA KEVIN J

(Last)

(First)

(Middle)

2600 CHEMED CENTER

255 EAST 5TH STREET

(Street)

CINCINNATI

OHIO

45202

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	president and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Capital Stock	03/27/2026		S		1,500	D	$369.37⁽¹⁾	92,219	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.76 to $373.24. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

	Kevin J. McNamara	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Chemed (CHE) report for Kevin J. McNamara?

Chemed reported that president and CEO Kevin J. McNamara executed an open-market sale of 1,500 shares of the company’s Capital Stock on March 27, 2026, at a weighted average price of $369.37 per share, according to a Form 4 insider trading report.

How many Chemed (CHE) shares did the CEO sell and at what price?

Kevin J. McNamara sold 1,500 shares of Chemed Capital Stock in an open-market transaction. The weighted average sale price was $369.37 per share, with individual trades executed at prices ranging from $365.76 to $373.24 during the reported transaction.

How many Chemed (CHE) shares does the CEO hold after this Form 4 sale?

After selling 1,500 shares, Chemed president and CEO Kevin J. McNamara directly holds 92,219 shares of the company’s stock. This post-transaction ownership figure is reported in the Form 4 as total shares following the transaction, reflecting his remaining direct stake.

Was the Chemed (CHE) CEO’s March 27, 2026 trade an open-market sale?

Yes. The Form 4 identifies the March 27, 2026 transaction by Kevin J. McNamara as an open-market sale of Chemed Capital Stock, coded as “S,” indicating a sale in the open market or a private transaction under SEC reporting rules for insiders.

What price range applied to the Chemed (CHE) CEO’s sold shares?

The Form 4 footnote states that Kevin J. McNamara’s sold shares were executed in multiple trades at prices ranging from $365.76 to $373.24. The reported transaction price of $369.37 per share represents a weighted average across all those individual sale executions.